Westfield Capital Management CO LP Mersana Therapeutics, Inc. Transaction History

Westfield Capital Management CO LP

  • $21.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$8.56 - $14.47 $18.1 Million - $30.5 Million
-2,108,810 Closed
0 $0
Q2 2021

Aug 10, 2021
BUY
$13.28 - $18.07 $1.46 Million - $1.99 Million
110,172 Added 5.51%
2,108,810 $28.6 Million
Q1 2021

May 14, 2021
BUY
$15.31 - $26.52 $23.5 Million - $40.7 Million
1,536,260 Added 332.25%
1,998,638 $32.3 Million
Q4 2020

Feb 12, 2021
BUY
$16.84 - $27.59 $7.79 Million - $12.8 Million
462,378 New
462,378 $12.3 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $198M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email